- Previous Close
393.00 - Open
392.51 - Bid 390.00 x --
- Ask 390.77 x --
- Day's Range
388.76 - 396.85 - 52 Week Range
286.26 - 480.00 - Volume
260,041 - Avg. Volume
554,960 - Market Cap (intraday)
37.862B - Beta (5Y Monthly) -0.33
- PE Ratio (TTM)
57.69 - EPS (TTM)
6.76 - Earnings Date --
- Forward Dividend & Yield 2.00 (0.51%)
- Ex-Dividend Date Jul 26, 2024
- 1y Target Est
--
APT Medical Inc. engages in the research, development, manufacturing, and supply of electrophysiology and vascular interventional medical devices in China. The company offers electrophysiological products comprising mapping catheters, ablation catheters, transseptal needle and sheaths, and steerable sheaths; and interventional cardiology and peripheral intervention products, such as introducer kits, guiding extension catheters, balloon catheters, guiding catheters, microcatheters, guidewires, hydrophilic angiographic catheters, hydrophilic guidewires, hemostatsis introducers, radial compression devices, aspiration catheters, inflation devices, Y connectors, snare kits, hemostasis valves, L guiding sheaths, balloon occlusion microcatheters, embolic protection device, transjugular liver access sets, and steerable guiding sheaths. It also provides OEM/ODM services, including project design and development, customization, and volume OEM, etc. APT Medical Inc. was founded in 2002 and is headquartered in Shenzhen, China.
www.aptmed.comRecent News: 688617.SS
View MorePerformance Overview: 688617.SS
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688617.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688617.SS
View MoreValuation Measures
Market Cap
38.15B
Enterprise Value
37.21B
Trailing P/E
58.12
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
19.52
Price/Book (mrq)
15.98
Enterprise Value/Revenue
18.97
Enterprise Value/EBITDA
50.88
Financial Highlights
Profitability and Income Statement
Profit Margin
32.60%
Return on Assets (ttm)
--
Return on Equity (ttm)
30.63%
Revenue (ttm)
2.07B
Net Income Avi to Common (ttm)
673.48M
Diluted EPS (ttm)
6.76
Balance Sheet and Cash Flow
Total Cash (mrq)
960.58M
Total Debt/Equity (mrq)
0.51%
Levered Free Cash Flow (ttm)
--